SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding

27 Mar 2025 10:25

RNS Number : 5017C
Rentokil Initial PLC
27 March 2025
Β 

Notification of transaction by a Person Discharging Managerial Responsibilities

Β 

Rentokil Initial plc (the 'Company') hereby announces that Andy Ransom, Chief Executive, a Person Discharging Managerial Responsibility, has exercised his award of 964,464 ordinary shares of 1 pence each in the Company granted under the Company Performance Share Plan 2006 (PSP) in March 2015.

The award, which vested in March 2018, would lapse this month if it remained unexercised.

453,914 of these shares have been sold to cover the tax and national insurance liability arising from the exercise at a price of Β£3.5633 per share, and the balance of shares has been retained.

The notification set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

Β 

Rachel Canham

Group General Counsel & Company Secretary

+44 (0)1293 858 000

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Andy Ransom

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Executive

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Rentokil Initial plc

b)

Β 

LEI

Β 

549300VN4WV7Z6T14K68

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of 1p each

Β 

Β 

ISIN: GB00B082RF11

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Exercise of options under the Performance Share Plan 2006 (883,906 nil-cost options, plus 80,558 shares in dividends equivalents).

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Nil consideration

964,464

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Total price

Β 

Β 

Β 

964,464

Β 

N/A

e)

Β 

Date of the transaction

Β 

2025-03-26

f)

Β 

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Andy Ransom

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Executive

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Rentokil Initial plc

b)

Β 

LEI

Β 

549300VN4WV7Z6T14K68

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of 1p each

Β 

Β 

ISIN: GB00B082RF11

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Part sale of shares to cover tax and NIC

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£3.5633

453,914

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Total price

Β 

Β 

Β 

453,914

Β 

Β£1,617,431.76

e)

Β 

Date of the transaction

Β 

2025-03-26

f)

Β 

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHGCGDXCSDDGUR
Date   Source Headline
30th Jan 20074:48 pmRNSHolding(s) in Company
25th Jan 200711:52 amRNSAnnual Calendar 2007
15th Jan 20073:00 pmRNSMerger Update
11th Jan 20075:10 pmRNSAcquisition
11th Jan 20071:36 pmRNSHolding(s) in Company
2nd Jan 20078:47 amRNSAcquisition
22nd Dec 20069:23 amRNSAcquisition
21st Dec 20061:01 pmRNSDirector/PDMR Shareholding
20th Dec 20061:18 pmRNSTotal Voting Rights
20th Dec 200611:08 amRNSDirector/PDMR Shareholding
18th Dec 20067:09 amRNSAcquisition
11th Dec 200611:30 amRNSHolding(s) in Company
7th Dec 200610:44 amRNSDirector/PDMR Shareholding
30th Nov 20067:04 amRNSReview Electronic Security
30th Nov 20067:01 amRNSAcquisition
24th Nov 20062:37 pmRNSHolding(s) in Company
24th Nov 20062:36 pmRNSHolding(s) in Company
10th Nov 200612:34 pmRNSClarification - Q3 Update
9th Nov 20065:07 pmRNSHolding(s) in Company
9th Nov 20069:57 amRNSInvestor Day
8th Nov 20067:01 amRNS3rd Quarter Results
3rd Nov 20068:00 amRNSFrance - Regulatory Inquiry
30th Oct 20065:45 pmRNSHolding(s) in Company
25th Oct 20063:34 pmRNSAcquisition
18th Oct 20065:15 pmRNSHolding(s) in Company
10th Oct 20062:33 pmRNSBank Facilities
25th Sep 20063:20 pmRNSReporting Timetable
24th Aug 20067:00 amRNSInterim Results
11th Aug 20062:39 pmRNSHolding(s) in Company
21st Jul 20069:12 amRNSDisposal
14th Jul 20062:34 pmRNSDirector Declaration
5th Jul 200611:37 amRNSAnnual Information Update
3rd Jul 20064:45 pmRNSHolding(s) in Company
30th Jun 20067:03 amRNSAcquisition
12th Jun 20065:12 pmRNSHolding(s) in Company
12th Jun 20068:09 amRNSDisposal
5th Jun 20065:03 pmRNSHolding(s) in Company
1st Jun 20064:59 pmRNSDirector/PDMR Shareholding
22nd May 20065:20 pmRNSHolding(s) in Company
22nd May 20065:18 pmRNSHolding(s) in Company
17th May 20064:40 pmRNSDirectorate Change
16th May 20062:43 pmRNSHolding(s) in Company
4th May 20067:01 amRNSTrading Statement
6th Apr 200610:42 amRNSDirector/PDMR Shareholding
6th Apr 200610:42 amRNSDirector/PDMR Shareholding
31st Mar 200612:36 pmRNSEMTN Programme
10th Mar 20062:14 pmRNSDisposal
10th Mar 20061:23 pmRNSHolding(s) in Company
8th Mar 200612:45 pmRNSPublication of Prospectus
7th Mar 20061:46 pmRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.